Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insulin: The Receptor and Signaling Pathways

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...

Hormones Regulating Blood Glucose

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Glucagon and beta-cell function changes before and after dietary weight loss-induced metabolic improvements in type 2 diabetes.

Diabetes research and clinical practice·2026

Same author

Effect of a Personalized Mobile App on Glucose Control in Adults With Prediabetes and Type 2 Diabetes: Exploratory Pilot Randomized Controlled Trial.

JMIR human factors·2026

Same author

Delphi-derived Framework for Healthspan-Oriented Care: The Cardiometabolic Health Perspective.

Aging and disease·2026

Same author

Early but not late time-restricted eating improves an actigraphy-estimated sleep quality in women with overweight or obesity: secondary analysis of the crossover ChronoFast trial.

Frontiers in nutrition·2026

Same author

Trace element dynamics following low-calorie formula diet and their association with glycaemic traits.

Clinical nutrition (Edinburgh, Scotland)·2026

Same author

Remodeling of human diurnal adipose tissue transcriptome by the composition of morning and afternoon meals.

Food research international (Ottawa, Ont.)·2026

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Published on: July 15, 2025

The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity.

Ayman M Arafat¹, Martin O Weickert, Jan Frystyk

¹Department of Endocrinology, Diabetes, and Nutrition, Charité-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany. ayman.arafat@charite.de

The Journal of Clinical Endocrinology and Metabolism

|October 23, 2009

Summary

Insulin acutely reduces insulin-like growth factor I (IGF-I) bioactivity by altering IGF-binding proteins (IGFBPs). IGFBP-2 is a key predictor of insulin sensitivity and is linked to metabolic syndrome.

Related Experiment Videos

Last Updated: Jun 19, 2026

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Published on: July 15, 2025

Area of Science:

Endocrinology
Metabolic Research
Molecular Biology

Background:

Insulin and the growth hormone-IGF system interact through reciprocal regulation of IGF-binding proteins (IGFBP) and GH.
This complex network influences insulin sensitivity via bioactive IGF-I and is implicated in metabolic syndrome and cardiovascular diseases.

Purpose of the Study:

To investigate the effects of glucose and insulin on IGFBP-1-4, with a focus on IGFBP-2.
To determine the role of IGFBP-2 in regulating bioactive IGF-I and its relationship with insulin resistance.

Main Methods:

Prospective study involving 24 healthy subjects and 19 subjects with impaired glucose tolerance (IGT).
Utilized oral glucose tolerance tests and hyperinsulinemic euglycemic clamps to assess metabolic parameters.
Analyzed levels of IGFBP-1-4, GH, and bioactive IGF-I under varying glucose and insulin conditions.

Main Results:

Insulin administration decreased IGF-I bioactivity in both groups.
Insulin increased IGFBP-2 and GH, while decreasing IGFBP-1 and -4.
IGT subjects exhibited greater insulin resistance and lower levels of GH, IGFBP-1, and IGFBP-2.
IGFBP-2 independently predicted insulin sensitivity and IGF-I bioactivity.

Conclusions:

Insulin acutely modulates IGF-I bioactivity through differential regulation of IGFBPs.
IGFBP-2 plays a crucial role in the cross-talk between the insulin and IGF systems.
IGFBP-2 is closely associated with insulin resistance, offering insights into its link with metabolic syndrome.